openPR Logo
Press release

Naloxone Market Analysis Industry 2019 | Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited

09-25-2019 03:47 PM CET | Health & Medicine

Press release from: CMI Research

Naloxone Market

Naloxone Market

Increasing launches and approval of novel naloxone products by various regulatory bodies is expected to be a major factor aiding in growth of the market over the forecast period. For instance, in January 2017, the U.S. Food and Drug Administration (FDA) approved Adapt Pharma Inc.’s NARCAN Nasal Spray 2 mg formulation for emergency treatment of known or suspected opioid overdose.

In 2016, Mylan N.V. launched its naloxone hydrochloride injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials. It is therapeutically equivalent to the naloxone hydrochloride injection 0.4 mg/mL, of Hospira Inc. In September 2017, Mundipharma International Limited received approval from European Medicines Agency (EMA) for its product (intranasal naloxone 1.8 mg) to use in emergency reversal of opioid overdose.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1804

Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October, 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada

Rising prevalence of opioid overdose in key regions such as North America, and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.

Furthermore, initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.

Key players operating in the naloxone market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1804

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Naloxone Market Analysis Industry 2019 | Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited here

News-ID: 1837515 • Views:

More Releases from CMI Research

Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune system rapid growth | Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline
Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune …
Eosinophilic Esophagitis (EoE) is a chronic inflammatory condition of the esophagus. It is characterized by the accumulation of a type of white blood cells called eosinophils in the lining of the esophagus. EoE can cause a range of symptoms, including difficulty swallowing, food impaction, chest pain, and heartburn. Steroids are the primary treatment option for EoE. They help control inflammation and reduce the number of eosinophils in the esophagus. Topical steroids
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for personalized medicine rapid growth | Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for person …
Adoptive cell therapy (ACT) is a form of immunotherapy that involves the genetic modification of T cells to enhance their cancer-fighting capabilities. This treatment has shown promising results in the treatment of several types of cancer and is expected to become a major player in the oncology market in the coming years. The global adoptive cell therapy market size was valued at USD 1.12 billion in 2021 and is projected to
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, key drivers and and future outlook 2030 | GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, ke …
Conjugate vaccine (Vi-TT) consists of Vi antigen that is coupled to a carrier protein. In this vaccine, polysaccharide is attached to a more complex protein. In infants, these cells can effectively develop immune protection against pathogens. Polysaccharides are weaker by itself, however, by binding to a protein carrier, polysaccharides can enter into important parts of the immune system with ease and can get more easily noticed by the immunity system
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, key drivers and challenges, and future outlook 2030 | Wellness Corporate Solutions, ComPsych Corporation, United Health Group
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, …
The corporate wellness market has been gaining popularity over the years as more companies recognize the importance of keeping their employees healthy and productive. Corporate wellness programs are designed to improve the overall health and well-being of employees by providing them with resources and support to manage their physical and mental health. The corporate wellness market is expected to grow significantly from 2023-2030. According to a report by Coherent Market Insights,

All 5 Releases


More Releases for Naloxone

Naloxone Spray Solutions: Global Demand and Forecast 2024
"The Business Research Company recently released a comprehensive report on the Global Naloxone Spray Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Naloxone Market Growing Demand for Effective Treatment Options
The Naloxone Market is a crucial segment within the pharmaceutical industry, focusing on the development, production, and distribution of naloxone, a medication designed to rapidly reverse opioid overdose. The market is experiencing substantial growth due to the increasing incidence of opioid overdoses, advancements in naloxone formulations, and heightened awareness and accessibility of this life-saving medication. The market's future looks promising with continuous advancements in naloxone formulations and the growing awareness
Global Naloxone Market Analysis and Forecast, 2022-2028
The global naloxone market is expected to reach a value of US$ 2.2 billion by 2028, growing at a CAGR of 11.1s% during the forecast period 2023-2028. Market Scope and Report Overview According to a deep-dive market assessment by RationalStat, the global naloxone market has been analyzed on the basis of market segments including route of administration, distribution channel, and geography/regions (incl. North America, Latin America, Western Europe, Eastern Europe, Middle East
Naloxone Market - Elevate community safety with our advanced Naloxone products: …
Newark, New Castle, USA: The "Naloxone Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Naloxone Market: https://www.growthplusreports.com/report/naloxone-market/8716 This latest report researches the industry structure, sales, revenue, price and
Naloxone Market Report, History and Forecast 2023-2031
Naloxone Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Naloxone industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2023 to 2031 time period. It presents a close overview of the
Naloxone Market To Cut Through Linear Growth
The Naloxone Market is expected to grow at an unstoppable rate In Upcoming Years. With environmental health being a matter of concern, everything - right from public transport networks, power supply, and storage of waste to monitoring the ecological balance is being taken up by IoT and AI. It could, thus, be inferred that with "smart cities" would come "smart end-user solutions" in the years to come. Naloxone is an opioid